Silvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, Maria T Acosta, Larry Alphs, Peter Annas, Pavel Balabanov, Anna-Karin Berger, Kim I Bishop, Florence Butlen-Ducuing, Georg Dorffner, Chris Edgar, Manuel de Gracia Blanco, Brian Harel, John Harrison, William P Horan, Judith Jaeger, Jan Kottner, Amy Pinkham, Daniella Tinoco, Monika Vance, Christian Yavorsky
Neurosciences clinical trials continue to have notoriously high failure rates. Appropriate outcomes selection in early clinical trials is key to maximizing the likelihood of identifying new treatments in psychiatry and neurology. The field lacks good standards for designing outcome strategies, therefore The Outcomes Research Group was formed to develop and promote good practices in outcome selection. This article describes the first published guidance on the standardization of the process for clinical outcomes in neuroscience...
April 3, 2024: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology